ANXA5 and neoplasm: A significantly higher number of CL1-5 (18.2% vs. 5.8%) and HT29 (24.4% vs 5.3%) tumor cells were double-labelled by Annexin-V and 7-ADD in HIS samples as compared to control samples (Figure 7C).